2018, 2019, 2020, 2021, and 2022, stock options granted on November 2, 2018 vested or vest in equal annual installments of approximately 33,825 on each of November 2, 2019, 2020, 2021, and 2022, stock options granted on February 24, 2020 vested or vest in equal annual installments of approximately 14,125 on each of February 24, 2021, 2022, 2023, and 2024, and stock options granted on March 1, 2021 vested or vest in equal annual installments of approximately 4,940 on each of March 1, 2022, 2023, 2024, and 2025, in each case subject to his continued employment with us. The restrictions on the time-vested restricted stock granted to Mr. Taylor on February 24, 2020 vested or vest in equal annual installments of approximately 1,787 on each of February 24, 2021, 2022, 2023, and 2024, and restricted stock granted on March 1, 2021 vested or vest in equal annual installments of approximately 2,156 on each March 1, 2022, 2023, 2024, and 2025, in each case subject to his continued employment with us. The restrictions on the PRSs granted to Mr. Taylor on February 24, 2020 lapse based on: (i) with respect to 86,656 shares subject to the PRSs, achievement of EBIT-based specified earnings and EBIT-based return-related targets as of the last day of the performance period ending on December 29, 2022 and continued employment with us through the date that the performance targets are measured; (ii) with respect to 56,461 shares subject to the PRSs, achievement of specified relative total shareholder return against a specified peer group as of the last day of the performance period ending on December 29, 2022 and continued employment with us through the date that the performance targets are measured; and (iii) with respect to 43,328 shares subject to the PRSs, continued service through the last day of the performance period.
(2)
Stock options granted to Mr. Lang on September 30, 2016 vested in equal annual installments of approximately 16,992 on each of September 30, 2017, 2018, 2019, 2020, and 2021, stock options granted on April 26, 2017 vested or vest over a 5-year period at a rate of 0%/10%/20%/30%/40% on April 26, 2018, 2019, 2020, 2021, and 2022, stock options granted on November 2, 2018 vested or vest in equal annual installments of 9,738 approximately on each of November 2, 2019, 2020, 2021, and 2022, stock options granted on February 24, 2020 vested or vest in equal annual installments of approximately 4,066 on each of February 24, 2021, 2022, 2023, and 2024, and stock options granted on March 1, 2021 vested or vest in equal annual installments of approximately 1,422 on each of March 1, 2022, 2023, 2024, and 2025, in each case subject to his continued employment with us. The restrictions on the time-vested restricted stock granted to Mr. Lang on February 24, 2020 vested or vest in equal annual installments of approximately 514 on each of February 24, 2021, 2022, 2023, and 2024, and restricted stock granted on March 1, 2021 vested or vest in equal annual installments of approximately 621 on each March 1, 2022, 2023, 2024 and 2025, in each case subject to his continued employment with us. The restrictions on the PRSs granted to Mr. Lang on February 24, 2020 lapse based on (i) with respect to 25,997 shares subject to the PRSs, achievement of EBIT-based specified earnings and EBIT-based return-related targets as of the last day of the performance period ending on December 29, 2022 and continued employment with us through February 24, 2024; (ii) with respect to 16,939 shares subject to the PRSs, achievement of specified relative total shareholder return against a specified peer group as of the last day of the performance period ending on December 29, 2022 and continued employment with us through February 24, 2024; and (iii) with respect to 12,999 shares subject to the PRSs, continued service through February 24, 2024.
(3)
Stock options granted to Ms. Laube on September 30, 2016 vested in equal annual installments of approximately 18,794 on each of September 30, 2017, 2018, 2019, 2020, and 2021, stock options granted on April 26, 2017 vested or vest over a 5-year period at a rate of 0%/10%/20%/30%/40% on April 26, 2018, 2019, 2020, 2021, and 2022, stock options granted on November 2, 2018 vested or vest in equal annual installments of approximately 10,763 on each of November 2, 2019, 2020, 2021, and 2022, stock options granted on February 24, 2020 vested or vest in equal annual installments of approximately 4,495 on each of February 24, 2022, 2023, and 2024, and stock options granted on March 1, 2021 vested or vest in equal annual installments of approximately 1,572 on each of March 1, 2022, 2023, 2024, and 2025, in each case subject to her continued employment with us. The restrictions on the time-vested restricted stock granted to Ms. Laube on February 24, 2020 vested or vest in equal annual installments of approximately 568 on each of February 24, 2021, 2022, 2023, and 2024, and restricted stock granted on March 1, 2021 vested or vest in equal annual installments of approximately 686 on each March 1, 2022, 2023, 2024 and 2025, in each case subject to her continued employment with us. The restrictions on the PRSs granted to Ms. Laube on February 24, 2020 lapse based on (i) with respect to 25,997 shares subject to the PRSs, achievement of EBIT-based specified earnings and EBIT-based return-related targets as of the last day of the performance period ending on December 29, 2022 and continued